Home
About
Publications Trends
Recent Publications
Expert Search
Archive
damage to dna
What Mechanisms Do Cells Employ to Repair DNA Damage?
Cells have several repair mechanisms to maintain genomic integrity:
Nucleotide excision repair
(NER): Repairs bulky DNA adducts and thymine dimers.
Base excision repair
(BER): Fixes small base modifications and single-strand breaks.
Mismatch repair
(MMR): Corrects errors that occur during DNA replication.
Homologous recombination
(HR): Repairs double-strand breaks using a sister chromatid as a template.
Non-homologous end joining
(NHEJ): Repairs double-strand breaks without a template.
Impairment in any of these repair pathways can lead to increased mutation rates and cancer development.
Frequently asked queries:
What is DNA Damage?
How Does DNA Damage Lead to Cancer?
What Are the Main Causes of DNA Damage in Cancer?
What Mechanisms Do Cells Employ to Repair DNA Damage?
How Are DNA Damage and Cancer Detected?
How Can DNA Damage Be Prevented?
What Are the Future Directions in DNA Damage and Cancer Research?
What are Exhausted T Cells?
What Role Does Data Analysis Play?
How Effective Are Pap Tests in Preventing Cervical Cancer?
How can healthcare providers support caregivers?
What Does a Five-Year Survival Rate Mean?
Are There Any Risks or Complications?
What Mechanisms Does PAX3 Use to Promote Cancer?
What Are the Current Applications and Future Directions?
What Are the Financial Implications of Medical Leave?
How Can Patients Access These Centers?
How is Lactate Metabolized in Cancer Cells?
How Are Familial Cancer Syndromes Diagnosed?
How Can Bioprinting Improve Personalized Cancer Treatments?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe